Immediate Impact
1 from Science/Nature 64 standout
Citing Papers
Type 2 Diabetes Mellitus: New Pathogenetic Mechanisms, Treatment and the Most Important Complications
2025 Standout
Tissue macrophages: origin, heterogenity, biological functions, diseases and therapeutic targets
2025 Standout
Works of Tonya Quinlan being referenced
Effects of Hepatic Impairment on the Pharmacokinetics of the Dual GIP and GLP-1 Receptor Agonist Tirzepatide
2022
LY3022855, an anti–colony stimulating factor-1 receptor (CSF-1R) monoclonal antibody, in patients with advanced solid tumors refractory to standard therapy: phase 1 dose-escalation trial
2021
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Tonya Quinlan | 180 | 44 | 115 | 57 | 16 | 372 | |
| Holly A. Gefroh | 58 | 48 | 116 | 20 | 10 | 354 | |
| Jun Miura | 79 | 46 | 68 | 66 | 24 | 386 | |
| Julie Eve Desmarais | 121 | 64 | 72 | 41 | 11 | 387 | |
| Niclas Lunder | 129 | 35 | 39 | 62 | 10 | 346 | |
| Hui Huang | 141 | 28 | 25 | 53 | 16 | 352 | |
| C. Lindsay DeVane | 186 | 78 | 112 | 13 | 12 | 423 | |
| Junzo Watanabe | 198 | 51 | 45 | 63 | 31 | 453 | |
| Richard Bergstrom | 158 | 50 | 97 | 39 | 16 | 450 | |
| Niko Seppälä | 238 | 11 | 49 | 30 | 20 | 380 | |
| Cara L. Alfaro | 158 | 89 | 59 | 33 | 10 | 362 |
All Works
Loading papers...